
Eventide Gilead Fund
ETGLX
Updated: 22/09/2026, 09:30:18
The Eventide Gilead Fund generally allocates its capital to a wide spectrum of equity instruments, without imposing any constraints based on the market capitalization of the companies. It possesses the flexibility to invest in businesses based outside the United States, either through direct ownership of their securities or by utilizing American Depositary Receipts (ADRs). Occasionally, the fund may opt to concentrate a considerable portion of its assets within particular economic sectors, such as technology, industrials, healthcare, and life sciences.
No summaries found.
- Share price
- $61.96
- Market cap
- $3.49B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 02/07/2008
- Beta
- 1.33
- Last dividend
- $0.00
- Day range
- $61.16 – $61.96
- 52-week range
- $48.82 – $67.01
- 1-day performance
- 1.31%
- 1-year performance
- 26.92%
- Current drawdown (1Y)
- -7.54%
- CIK
- 0001355064
- CUSIP
- 62827L682
- ISIN
- US62827L6829
- Created
- 07/12/2025, 03:50:30
- Last update
- 22/09/2026, 09:30:18
Track Eventide Gilead Fund with an AI analyst
See which prediction-market events move ETGLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.